Creation of a Long-Acting Rilpivirine Prodrug Nanoformulation

Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore immune function, and improve quality of life. As a treatment alternative, long-acting (LA) antiretrovirals can sustain therapeutic drug concentrations in blood for prolonged time periods. The success of recent...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Control Release
Päätekijät: Hilaire, James R., Bade, Aditya N., Sillman, Brady, Gautam, Nagsen, Herskovitz, Jonathan, Shetty, Bhagya Laxmi Dyavar, Wojtkiewicz, Melinda S., Szlachetka, Adam, Lamberty, Ben, Sravanam, Sruthi, Fox, Howard, Alnouti, Yazen, Dash, Prasanta K., McMillan, JoEllyn M., Edagwa, Benson J., Gendelman, Howard E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875695/
https://ncbi.nlm.nih.gov/pubmed/31491432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.09.001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia